基本信息
浏览量:7
职业迁徙
个人简介
Matthew T. Drake, M.D., Ph.D., studies bone loss across both normal and disease states. Specifically, Dr. Drake is interested in the mechanisms underlying age-related bone loss and the skeletal microarchitectural changes that accompany this condition. Additionally, he is working toward a better understanding of the effect of cancer on the skeleton, and particularly of the mechanisms at the root of skeletal metastasis and malignancy-associated bone loss.
Focus areas
Monoclonal gammopathy bone disease. Dr. Drake is the program director and principal investigator (PI) on a study focused on the origins and development of monoclonal gammopathy bone disease, with funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Multiple myeloma. Dr. Drake led an investigation, funded by the Multiple Myeloma Research Foundation, aimed at better understanding how the disease causes bone destruction. He was also the PI on Mayo Clinic studies looking specifically at the molecular basis for bone destruction in multiple myeloma as well as bone microarchitecture in multiple myeloma, smoldering multiple myeloma, and monoclonal gammopathy of undetermined significance (MGUS).
Significance to patient care
The long-term aim of Dr. Drake's research is to improve understanding of how both normal aging and the presence of malignancies can lead to the softening or destruction of bone mass, with the ultimate goal of contributing to new or improved methods for the prevention and treatment of bone loss.
Professional highlights
Independent content reviewer, Task Force on Cell-Based Therapies, American Society for Bone and Mineral Research (ASBMR), 2014-present
Member, Task Force on Managing Osteoporosis Patients after Long-Term Bisphosphonate Treatment, ASBMR, 2013-present
Scientific Advisory Board, Soft Bones Foundation, 2012-present
New Investigator Award, Mayo Clinic Department of Medicine, 2010
Young Investigator Award, ASBMR, 2009
Focus areas
Monoclonal gammopathy bone disease. Dr. Drake is the program director and principal investigator (PI) on a study focused on the origins and development of monoclonal gammopathy bone disease, with funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Multiple myeloma. Dr. Drake led an investigation, funded by the Multiple Myeloma Research Foundation, aimed at better understanding how the disease causes bone destruction. He was also the PI on Mayo Clinic studies looking specifically at the molecular basis for bone destruction in multiple myeloma as well as bone microarchitecture in multiple myeloma, smoldering multiple myeloma, and monoclonal gammopathy of undetermined significance (MGUS).
Significance to patient care
The long-term aim of Dr. Drake's research is to improve understanding of how both normal aging and the presence of malignancies can lead to the softening or destruction of bone mass, with the ultimate goal of contributing to new or improved methods for the prevention and treatment of bone loss.
Professional highlights
Independent content reviewer, Task Force on Cell-Based Therapies, American Society for Bone and Mineral Research (ASBMR), 2014-present
Member, Task Force on Managing Osteoporosis Patients after Long-Term Bisphosphonate Treatment, ASBMR, 2013-present
Scientific Advisory Board, Soft Bones Foundation, 2012-present
New Investigator Award, Mayo Clinic Department of Medicine, 2010
Young Investigator Award, ASBMR, 2009
研究兴趣
论文共 156 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
R.H. Lee, J. Curtis,M.T. Drake, S. Bobo Tanner IV,L. Lenert,K. Schmader,C. Pieper, R. North, K.W. Lyles
Osteoporosis Internationalno. 1 (2024): 181-187
The Lancet Diabetes & Endocrinology (2024)
Clinical medicine (London, England)no. 5 (2023): 503-507
Angelo Jose Guilatco,Gabriel Álvares Borges,Tamar Tchkonia,James L. Kirkland,Taxiarchis Kourelis,Matthew T. Drake,Megan M. Weivoda
引用0浏览0引用
0
0
Gabriel Alvares Borges,Marta Diaz-Delcastillo,Angelo Jose Guilatco, Fatima Ali Mustapha, Bilal El Masari,Michael Tveden Gundesen,Maja Hinge, Charlotte Guldborg Nyvold,Thomas Lund,Tamar Tchkonia,James L. Kirkland,Taxiarchis Kourelis,
Bloodno. Supplement 1 (2023): 1944-1944
Metabolism: clinical and experimental (2023): 155553-155553
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn